Pharmaceutical giant Novo Nordisk on Tuesday dropped the price of its popular weight loss drug, Wegovy, by 37% — from a weekly price of Rs 4,336 to Rs 2,712 for its lowest 0.25 mg dose. The highest 2.4 mg dose of Wegovy will now be priced at Rs 4,100 a week, translating to around Rs16,400 a month. This will make the drug significantly cheaper than its competitor Eli Lilly’s Mounjaro.

The price drop comes at a time when Eli Lilly has been steadily capturing the weight loss market in India, entering the market months before Novo Nordisk. Mounjaro is priced at Rs 3,500 per 2.5 mg single-dose vial and Rs 4,375 per 5 mg single-dose vial, adding up to anywhere between Rs 14,000 to Rs 17,500 a month. When it comes to its easy use KwikPen, the highest 15 mg dose is available at the cost of Rs 27,

See Full Page